Prostate-specific membrane antigen (PSMA, folate hydrolase I, glutamate carboxypeptidase II) is a type II transmembrane glycoprotein that is expressed in benign prostatic tissue and at higher levels in prostate cancer (1–3). Here, FOLH1 is linked to prostate carcinoma.